Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Accounts Payables: 2023-2024

Historic Accounts Payables for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $5.9 million.

  • Zhengye Biotechnology Holding's Accounts Payables was N/A to -$209,176 in Q2 2025 from the same period last year, while for Jun 2025 it was -$209,176, marking a year-over-year change of. This contributed to the annual value of $5.9 million for FY2024, which is 8.91% down from last year.
  • Zhengye Biotechnology Holding's Accounts Payables amounted to $5.9 million in FY2024, which was down 8.91% from $6.5 million recorded in FY2023.
  • Zhengye Biotechnology Holding's Accounts Payables' 5-year high stood at $6.5 million during FY2023, with a 5-year trough of $5.9 million in FY2024.
  • Its 2-year average for Accounts Payables is $6.2 million, with a median of $6.2 million in 2024.
  • Data for Zhengye Biotechnology Holding's Accounts Payables shows a maximum YoY fell of 8.91% (in 2024) over the last 5 years.
  • Zhengye Biotechnology Holding's Accounts Payables (Yearly) stood at $6.5 million in 2023, then decreased by 8.91% to $5.9 million in 2024.